Dr. Carlos Fares Bechara, MD

Dr. Bechara practices at Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois.

Dr. Bechara's NPI, 1639357585, was assigned on February 2, 2008. Dr. Bechara graduated from American University of the Caribbean School of Medicine in 2001. Dr. Bechara holds Illinois license 036142655.

Dr. Bechara's primary practice is Loyola Medicine Pediatric Mobile Health Unit, at 2160 S 1st Avenue, Maywood, IL 60153. The practice phone is (708) 216-3299.

Dr. Bechara's primary practice is Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois. Dr. Bechara is also affiliated with Loyola University Medical Center. The medical group on file is Rush University Internists. Dmand AI also links Dr. Bechara to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bechara practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Bechara's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Bechara is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Bechara's licenses on file in 4 states: Illinois, Indiana, Texas and Louisiana.

Dmand AI lists aortic atherosclerois, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Bechara treats.

CMS data shows 680 Medicare services from Dr. Bechara across 17 procedure codes in 2024, for 506 Medicare patients. Medicare paid $33,465 for them.

CMS counts 506 Medicare patients who saw Dr. Bechara in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bechara's median patient age at 73, with 44% women.

In 2024, Dr. Bechara wrote 72 Medicare Part D claims for 29 patients. 78% of them were for generic drugs. CMS names the drug for 35 of them, across 1 drug with 11 or more claims each, at $417 in total drug cost. In 2023, CMS named 66 claims across 3 drugs.

Dr. Bechara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bechara as offering telehealth. CMS counts 31 procedures of leg revascularization (restoring blood flow) by Dr. Bechara, more than 89% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 121 papers to Dr. Bechara, published from 2008 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Stents. Dr. Bechara has published most often in Ann Vasc Surg. Dr. Bechara's most frequent co-authors are Peter H. Lin, MD, George Pisimisis, MD and Panagiotis Kougias, MD.

CMS Open Payments shows 626 general payments to Dr. Bechara from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 26% of the total. Cook Medical LLC paid the most, $148,640.

Dr. Bechara graduated from American University of the Caribbean School of Medicine in 2001.

Dr. Bechara is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.